Taken together with the recent report advocating for pharmacological blockade of p28 as a potential therapy for GVHD, our results unambiguously demonstrate that IL-27 signaling on T cells exacerbates GVHD after allo-HCT. Here, IL27 is linked to graft versus host disease.